Is NCV undervalued? Our fair value estimate

NCV · Financial Services · NYQ

Our fair value estimate
USD36.52
Current share price
USD16.86
Upside to fair value
+116.6%
Screens as clearly undervalued. NCV trades 117% below the USD36.52 our model puts on the business. A fair value estimate is an argument, not a measurement: it is only as good as its growth assumption, and the market is frequently right about why something trades where it does.
Overall rating: 82/100, Strong BuyMoat score: 66/100Data quality: high confidence (100/100 of the inputs on file)

How we got here

The estimate is computed from NCV's reported fundamentals, with a growth assumption that is deliberately capped: small changes to an uncapped growth or terminal assumption can justify any price, and a number that can justify anything means nothing. These are the inputs the model holds for NCV today; the exact method, and where it goes wrong, is on the methodology page.

Earnings multiple4.5x

The starting point is earnings power: what the business earns per share, and what the market currently pays for each unit of it.

Revenue growth (YoY)-10.5%

The trailing growth rate informs the growth assumption, which the model caps deliberately: uncapped growth assumptions can justify any price.

Profit margin351.1%

Margins tell the model how much of each unit of revenue survives as profit, and how much room there is for that to erode.

Return on equity16.5%

Persistent high returns on capital are what a moat looks like in the accounts, and they feed the moat score alongside the valuation.

Beta1.19

A volatility measure against the wider market. A jumpier share earns a larger discount for risk, which lowers the estimate.

Debt to equity0.22

Leverage haircuts the estimate: debt claims cash before shareholders do, and it turns bad years into dangerous ones.

The belief gap: what growth this price asks you to believe

Run our DCF backwards and every price becomes a growth assumption. One axis compares them: today's market price, the entry prices implied by super investors' 13F filings, the mean analyst target, and the growth our own model funds. The gap between the market's marker and the cohort's markers is the growth you are being asked to believe that informed buyers did not need.

Our model5.0%
0% growth12% annual cash-flow growth

No growth rate between 0% and 30% makes our model's fair value equal today's price, so the market is pricing something our DCF cannot express. Our model funds 5.0%.

Millennium Management's Q1 2026 filing implies an average entry near $14.88, which implied a growth rate outside our model's 0-30% band under our model.

Entry prices are filing-implied averages (reported position value divided by reported shares for the quarter a position was opened or materially increased), not actual cost bases; 13Fs lag by up to 45 days. How the Belief Gap is computed.

Common questions

Is NCV (NCV) undervalued?

On our model, NCV at USD16.86 trades 117% below our fair value estimate of USD36.52, so it screens as undervalued today. That is one model's answer, not a recommendation: a fair value estimate is an argument about the future, and the market is frequently right about why something is cheap.

What is the fair value of NCV?

Our current fair value estimate for NCV is USD36.52 per share. The estimate moves as prices and fundamentals move.

How is NCV's fair value calculated?

From NCV's reported fundamentals: earnings power, a deliberately capped growth assumption, and a discount for balance sheet and volatility risk. The full method, including its known weaknesses, is published on our methodology page, and the interactive Valuation Lab lets you change every assumption and watch the value move.

Disagree with an assumption? Good. The Valuation Lab on the NCV app page puts every input of this model on a slider, including a reverse DCF that shows the growth the market is currently pricing in.

A fair value estimate is a model output computed from company filings and market data, refreshed daily; quotes are delayed. It is educational information, not financial advice and not a recommendation to buy or sell anything. Read the full disclaimer.